- Johnson & Johnson stock price today and history
Johnson & Johnson (JNJ) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
Johnson & Johnson stock price
Johnson & Johnson latest news:
Pfizer accuses Johnson & Johnson of 'anticompetitive practices' in lawsuit
Pfizer filed a lawsuit against fellow pharmaceutical giant Johnson & Johnson over "anticompetitive practices" with the drug Remicade.
Pfizer files suit against J&J over Remicade contracts
(Reuters) - Drugmaker Pfizer Inc on Wednesday filed a lawsuit against Johnson & Johnson , saying its rival's contracts with health insurers for blockbuster rheumatoid arthritis drug, Remicade, were anticompetitive and blocked sales of Pfizer's new biosimilar.
Vertex Pharma surges 1% after news of new CFO
Vertex Pharmaceuticals Inc. shares surged 1.2% in premarket trade Wednesday after the company announced that Tom Graney would be its new chief financial officer and senior vice president, starting September 13. Graney will report to Ian Smith, Vertex's chief operating officer and executive vice president, who has been Vertex's chief financial officer for 16 years. Graney most recently served as CFO and senior vice president of finance and corporate strategy at Ironwood Pharmaceuticals . Graney was in his Ironwood Pharma position for just over three years, according to his LinkedIn profile; he previously worked at Johnson & Johnson and its Ethicon and Janssen business units, among other places. Vertex shares have surged 24.6% to $159.07 over the last three months, compared with a 1.2% rise in the S&P 500 .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Travelers stock weighs on Dow industrials in late trade
The Dow Jones Industrial Average on Wednesday was seeing modest gains capped in late-afternoon trade partly on the back of a decline in insurer Travelers Cos. Inc. in the wake of the Hurricane Harvey. The Dow briefly slipped into negative territory, with Travelers stock down 1% as the impact of a now-Tropical storm Harvey was being assessed in the Houston and Louisiana area. Some estimates peg losses in the Gulf Coast region at around $160 billion, which could hit insurance companies. Meanwhile, shares of Johnson & Johnson and UnitedHealth Group Inc. were also pressuring the blue-chip benchmark. Most recently, the Dow was up less than 0.1% at 21,885, while the S&P 500 index climbed 0.5%, and the Nasdaq Composite Index looked on track to post a more than 1% advance. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
U.S. stocks close lower after Trump threatens to shut down the government
U.S. stocks ended with modest losses on Wednesday, after President Donald Trump threatened to shut down the U.S. government if Congress doesn't fund his campaign pledge to build a wall on the Mexican border, a policy with low approval ratings in Congress. The Dow Jones Industrial Average fell 0.4% to 21,813. The S&P 500 lost 0.4% to 2,444. The Nasdaq Composite Index ended down by 0.3% to 6,278. Traders were also cautious ahead of the Jackson Hole, Wyo., meeting of global central bankers, which could provide new insights into what global monetary policy will look like going forward. The day's losses were broad-based, with eight of the 11 primary S&P 500 sectors lower on the day. Material stocks were among the hardest hit, off 0.9%. Among specific stocks, Johnson & Johnson was one of the biggest drags on the day, falling 1.4%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Jury awards $417M in another Johnson & Johnson talc cancer case
The lawsuit brought by a California woman alleges Johnson & Johnson failed to adequately warn consumers about the potential cancer risks of talcum powder.
Johnson & Johnson faces $417m payout in latest talc case
The payout - to a woman who developed ovarian cancer - is the largest award so far against the firm.
Jury awards $417M in lawsuit linking talcum powder to cancer
A Los Angeles jury on Monday ordered Johnson & Johnson to pay $417 million to a woman who claimed in a lawsuit that the talc in its iconic baby powder causes ovarian cancer when applied regularly for feminine hygiene.
UPDATE 1-J&J ordered to pay $417 mln in trial over talc cancer risks
Aug 21 (Reuters) - Johnson & Johnson on Monday was ordered
by a California jury to pay $417 million to a woman who claimed
she developed ovarian cancer after using the company's
talc-based products like Johnson's Baby Powder for feminine
J&J ordered to pay $417 million in trial over talc cancer risks
(Reuters) - Johnson & Johnson on Monday was ordered by a California jury to pay $417 million to a woman who claimed she developed ovarian cancer after using the company's talc-based products like Johnson's Baby Powder for feminine hygiene.
Bayer, J&J win third U.S. trial over Xarelto bleeding risk
Aug 18 (Reuters) - A federal jury has cleared Bayer AG
and Johnson & Johnson of liability in the
third case to go to trial out of thousands of lawsuits claiming
the drugmakers' blood thinner Xarelto led to severe internal
Dow futures are down but individual Dow stocks suggest win streak set to continue
Although Dow industrials futures are 14 down points ahead of Tuesday's open, suggesting the Dow Jones Industrial Average's win streak will be snapped at 10 sessions, an analysis of individual Dow components trading premarket suggests the streak of gains are set to continue. Of the 27 Dow components that have traded ahead of the open, 17 are gaining ground. Overall, the components' premarket moves suggests the Dow would be up 11.5 points. Among the biggest contributors to the Dow's move, shares of Boeing Inc. would add 8.8 points to the Dow, McDonald's Corp. would add 3.6 points and American Express Co. would add 2.7 points. Meanwhile, Shares of 3M Co. would shave off 3 points, Goldman Sachs Group Inc. would take away 2.9 points, Johnson & Johnson would detract 2.3 points and Apple Inc. would shave off 1.6 points.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
S&P, Dow lower as J&J drags; Nasdaq hits record
(Reuters) - The S&P 500 and the Dow Jones Industrial Average were pulled lower by losses in Johnson & Johnson in early afternoon trading on Monday, while the Nasdaq hit a record high ahead of Google parent Alphabet's earnings report.
Why Credit Suisse Prefers Johnson & Johnson Over Pfizer
Johnson & Johnson Shares Slip Following Mixed Earnings
Jones Lang LaSalle IncorporatedJLL
Journal Media GroupJMG
Joy Global Inc.JOY
JP Energy Partners LPJPEP
JPMorgan China Region FundJFC
Jumei International Holding LimitedJMEI
Jupai Holdings LimitedJP